Presentation and Management of Interstitial Lung Disease ILD

Details

Title

Presentation and Management of Interstitial Lung Disease ILD

Type

Stage Two

Module code

HPS164

Requirement

Compulsory

Module objective

By the end of this module the Clinical Scientist in HSST, with respect to the diagnosis, presentation and management of patients with stable ILD, will be able to analyse, synthesise, evaluate and apply their knowledge, to be competent to carry out specialist assessment and form a structured differential diagnosis of causes leading to appropriate further investigation and effective management, within the scope of a Consultant Clinical Scientist. Clinical Scientists in HSST will be competent in the management of the common disease entities in this category and have some knowledge/experience of the less common diseases, including orphan lung diseases and recognise the requirement for medical assistance

Knowledge and understanding

By the end of this module the Clinical Scientist in HSST will analyse, synthesise, evaluate and critically apply their expert knowledge required with respect to: 

• the common diseases included in this category.
• less common disease entities.
• the causes of ILD.
• differential diagnosis of ILD.
• the investigation of ILD.
• the assessment of disease severity.
• the role of transplantation.
• the pharmacology of drugs used, and understanding of risk/benefit issues in treatment.
• the complications of ILD.
• the relevant guidelines/NSF.

Technical and clinical skills

By the end of this module the Clinical Scientist in HSST will be expected to critically reflect and apply in practice a range of clinical and communication skills to advise and communicate effectively with patients with stable ILD, relevant clinicians, patients and the public and other healthcare professionals and will:

• gain informed consent.
• take a thorough, focused history within limits of respiratory practice.
• elicit relevant and appropriate physical signs within Consultant Clinical Scientist scope of practice.
• plan appropriate investigations in collaboration with medical colleagues where necessary.
• formulate an appropriate differential diagnosis and management plan.
• interpret appropriate Lung Function Tests.
• collaborate with patient to produce an appropriate management plan.
• interpret Chest Radiology.
• non-invasive ventilation.

Attitudes and behaviours

By the end of this module the Clinical Scientist in HSST will be expected to evaluate their own response to both normal and complex situations demonstrating the professional attributes and insights required of a Consultant Clinical Scientist working within the limits of professional competence referring as appropriate to senior staff and will:

• involve patient in management decisions, particularly with regard to risk/benefit issues of treatment in conjunction with clinical colleagues and “ceiling of care” apropos mechanical ventilation
• inform patient, where appropriate, of prognosis and the requirement for clinician support
• provide patient/carer support in poorer prognosis disease
• work to relieve symptoms where disease course cannot be beneficially affected and the requirement for clinician support
• consider the possible role for palliative care team
• recognise the role for an MDT approach to management